Development of genetic, metabolic and neuroimaging-based biomarkers will be essential to the management of neurodegenerative disorders.18 GLP-1RAs have demonstrated effective anti-inflammatory properties and can improve insulin signalling, which supports a common biochemical pathway across neurodegenerative indications.38 Development of biomarkers that describe sensitivity of brain tissue to insulin may provide clinical guidance to help determine which individuals would respond to GLP-1RAs or combination therapies, which could in turn improve adherence and overall efficacy of intervention.22 In addition, sensitive biomarkers of neuroinflammation can advance targeted drug development in this area by allowing the demonstration of target engagement
Understanding the mechanism helps explain why its effects are so broad
The investigators assessed body-weight change, food intake, resting energy expenditure, fat oxidation, glucose oxidation, plasma glucose, insulin, and plasma glycerol
We highlight how multireceptor agonists and oral GLP-1based therapies may reshape the future landscape of obesity and type 2 diabetes treatment by offering more effective and better-tolerated options
The use of L-Carnitine supplement without a proper exercise routine will not be helpful in the long run